Recent studies have reported that LSR downregulation inhibits cell proliferation and invasion in endometrial cancer (27, 28), while its overexpression in gastric and breast cancers correlates with increased lipid uptake, cell proliferation, and cancer stem cell-like features (29, 30). The gene discussed is LSR; the disease is cancer.